166 related articles for article (PubMed ID: 29441975)
1. Novel insights into the pharmacological effects of resveratrol on the management of depression: a short review.
Xu YY; Liang J; Xia QR
Pharmazie; 2017 Sep; 72(9):499-502. PubMed ID: 29441975
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant-like effect of resveratrol: involvement of antioxidant effect and peripheral regulation on HPA axis.
Ge JF; Peng L; Cheng JQ; Pan CX; Tang J; Chen FH; Li J
Pharmacol Biochem Behav; 2013 Dec; 114-115():64-9. PubMed ID: 24201049
[TBL] [Abstract][Full Text] [Related]
3. The effect of trans-resveratrol on post-stroke depression via regulation of hypothalamus-pituitary-adrenal axis.
Pang C; Cao L; Wu F; Wang L; Wang G; Yu Y; Zhang M; Chen L; Wang W; Lv W; Chen L; Zhu J; Pan J; Zhang H; Xu Y; Ding L
Neuropharmacology; 2015 Oct; 97():447-56. PubMed ID: 25937213
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice.
Ali SH; Madhana RM; K V A; Kasala ER; Bodduluru LN; Pitta S; Mahareddy JR; Lahkar M
Steroids; 2015 Sep; 101():37-42. PubMed ID: 26048446
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK.
Wang Z; Gu J; Wang X; Xie K; Luan Q; Wan N; Zhang Q; Jiang H; Liu D
Pharmacol Biochem Behav; 2013 Nov; 112():104-10. PubMed ID: 24125781
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like Effect of Bacopaside I in Mice Exposed to Chronic Unpredictable Mild Stress by Modulating the Hypothalamic-Pituitary-Adrenal Axis Function and Activating BDNF Signaling Pathway.
Zu X; Zhang M; Li W; Xie H; Lin Z; Yang N; Liu X; Zhang W
Neurochem Res; 2017 Nov; 42(11):3233-3244. PubMed ID: 28758176
[TBL] [Abstract][Full Text] [Related]
8. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
Budziszewska B
Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol abrogates lipopolysaccharide-induced depressive-like behavior, neuroinflammatory response, and CREB/BDNF signaling in mice.
Ge L; Liu L; Liu H; Liu S; Xue H; Wang X; Yuan L; Wang Z; Liu D
Eur J Pharmacol; 2015 Dec; 768():49-57. PubMed ID: 26485503
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol exerts antidepressant properties in the chronic unpredictable mild stress model through the regulation of oxidative stress and mTOR pathway in the rat hippocampus and prefrontal cortex.
liu S; Li T; Liu H; Wang X; Bo S; Xie Y; Bai X; Wu L; Wang Z; Liu D
Behav Brain Res; 2016 Apr; 302():191-9. PubMed ID: 26801825
[TBL] [Abstract][Full Text] [Related]
11. [The role of the hypothalamo-hypophyseal-adrenocortical system in the specific activity of antidepressive agents].
Arushanian EB; El'bek'ian KS
Eksp Klin Farmakol; 1995; 58(3):65-70. PubMed ID: 7663305
[TBL] [Abstract][Full Text] [Related]
12. Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model.
Jindal A; Mahesh R; Bhatt S; Pandey D
Neurochem Int; 2017 Dec; 111():3-11. PubMed ID: 27988361
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like effect of the water extract of the fixed combination of Gardenia jasminoides, Citrus aurantium and Magnolia officinalis in a rat model of chronic unpredictable mild stress.
Xing H; Zhang K; Zhang R; Shi H; Bi K; Chen X
Phytomedicine; 2015 Dec; 22(13):1178-85. PubMed ID: 26598917
[TBL] [Abstract][Full Text] [Related]
14. The neurobiology of depression and antidepressant action.
Willner P; Scheel-Krüger J; Belzung C
Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2331-71. PubMed ID: 23261405
[TBL] [Abstract][Full Text] [Related]
15. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
Nikisch G
Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
[TBL] [Abstract][Full Text] [Related]
16. Piper sarmentosum Roxb. produces antidepressant-like effects in rodents, associated with activation of the CREB-BDNF-ERK signaling pathway and reversal of HPA axis hyperactivity.
Li Q; Qu FL; Gao Y; Jiang YP; Rahman K; Lee KH; Han T; Qin LP
J Ethnopharmacol; 2017 Mar; 199():9-19. PubMed ID: 28126450
[TBL] [Abstract][Full Text] [Related]
17. Novel agents in development for the treatment of depression.
Grady MM; Stahl SM
CNS Spectr; 2013 Dec; 18 Suppl 1():37-40; quiz 41. PubMed ID: 24252548
[TBL] [Abstract][Full Text] [Related]
18. Use of endocrine hormones for treating depression.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Dec; 48(12):13-6. PubMed ID: 21117521
[TBL] [Abstract][Full Text] [Related]
19. Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression.
Peng GJ; Tian JS; Gao XX; Zhou YZ; Qin XM
Curr Neuropharmacol; 2015; 13(4):514-23. PubMed ID: 26412071
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]